Impact of the fetal fibronectin assay on admissions for preterm labor
- 1 March 1999
- journal article
- Published by Elsevier BV in American Journal of Obstetrics and Gynecology
- Vol. 180 (3), 581-586
- https://doi.org/10.1016/s0002-9378(99)70258-9
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Fetal fibronectin as a predictor of preterm birth in patients with symptoms: A multicenter trialAmerican Journal of Obstetrics and Gynecology, 1997
- The preterm prediction study: Fetal fibronectin testing and spontaneous preterm birthObstetrics & Gynecology, 1996
- Reduced Incidence of Preterm Delivery with Metronidazole and Erythromycin in Women with Bacterial VaginosisNew England Journal of Medicine, 1995
- Fetal fibronectin improves the accuracy of diagnosis of preterm laborAmerican Journal of Obstetrics and Gynecology, 1995
- Pregnancy Complications Associated With Bacterial Vaginosis and Their Estimated CostsInfectious Diseases in Obstetrics and Gynecology, 1995
- Genital Mycoplasmas in Placental InfectionsInfectious Diseases in Obstetrics and Gynecology, 1994
- Fetal fibronectin in patients at increased risk for premature birthAmerican Journal of Obstetrics and Gynecology, 1994
- Bacterial Vaginosis and Anaerobes in Obstetric-Gynecologic InfectionClinical Infectious Diseases, 1993
- Fetal Fibronectin in Cervical and Vaginal Secretions as a Predictor of Preterm DeliveryNew England Journal of Medicine, 1991
- The oncofetal domain of fibronectin defined by monoclonal antibody FDC-6: its presence in fibronectins from fetal and tumor tissues and its absence in those from normal adult tissues and plasma.Proceedings of the National Academy of Sciences of the United States of America, 1985